AcuCort AB (publ) (XSAT:ACUC)
Sweden · Delayed Price · Currency is SEK 0.5340
-0.0160 (-2.91%)
At close: Sep 15, 2026
AcuCort AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 10.37 | 27.01 | 2.77 | 19.24 | 17.18 | 35.85 |
Cash & Short-Term Investments | 10.37 | 27.01 | 2.77 | 19.24 | 17.18 | 35.85 |
Cash Growth | -68.03% | 874.46% | -85.60% | 12.01% | -52.08% | 49.57% |
Other Receivables | 2.25 | 0.58 | 0.6 | 0.46 | 0.35 | 0.41 |
Receivables | 2.25 | 0.58 | 0.6 | 0.46 | 0.35 | 0.41 |
Prepaid Expenses | 0.93 | 0.21 | 0.36 | 0.64 | 0.62 | 0.52 |
Total Current Assets | 13.56 | 27.8 | 3.74 | 20.34 | 18.15 | 36.78 |
Other Intangible Assets | 2.99 | 3.48 | 4.48 | 4.97 | 4.95 | 4.84 |
Long-Term Deferred Charges | 35.62 | 35.9 | 37.06 | 33.19 | 26.6 | 21.58 |
Total Assets | 52.17 | 67.18 | 45.27 | 58.51 | 49.7 | 63.2 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.47 | 1.73 | 2.63 | 3.05 | 1.23 | 1.08 |
Accrued Expenses | 1.7 | 1.52 | 1.47 | 3.03 | 2.74 | 1.65 |
Current Income Taxes Payable | - | 0 | 0.02 | 0.02 | 0.02 | 0.02 |
Other Current Liabilities | 0.29 | 0.19 | 0.3 | 4.88 | 0.12 | 0.07 |
Total Current Liabilities | 3.46 | 3.44 | 4.42 | 10.98 | 4.12 | 2.83 |
Total Liabilities | 3.46 | 3.44 | 4.42 | 10.98 | 4.12 | 2.83 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 89.09 | 89.09 | 45.28 | 31.86 | 31.28 | 31.28 |
Additional Paid-In Capital | 105.2 | 105.2 | 99.92 | 102.63 | 87.56 | 87.56 |
Retained Earnings | -145.58 | -130.54 | -104.35 | -86.96 | -73.26 | -58.48 |
Shareholders' Equity | 48.71 | 63.74 | 40.85 | 47.53 | 45.58 | 60.37 |
Total Liabilities & Equity | 52.17 | 67.18 | 45.27 | 58.51 | 49.7 | 63.2 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash (Debt) | 10.37 | 27.01 | 2.77 | 19.24 | 17.18 | 35.85 |
Net Cash Growth | -68.03% | 874.46% | -85.60% | 12.01% | -52.08% | 49.57% |
Net Cash Per Share | 0.04 | 0.12 | 0.03 | 0.62 | 0.55 | 1.84 |
Filing Date Shares Outstanding | 234.44 | 234.44 | 119.17 | 83.83 | 31.28 | 31.28 |
Total Common Shares Outstanding | 234.44 | 234.44 | 119.17 | 83.83 | 31.28 | 31.28 |
Working Capital | 10.1 | 24.36 | -0.68 | 9.37 | 14.03 | 33.95 |
Book Value Per Share | 0.21 | 0.27 | 0.34 | 0.57 | 1.46 | 1.93 |
Tangible Book Value | 45.72 | 60.26 | 36.37 | 42.56 | 40.63 | 55.53 |
Tangible Book Value Per Share | 0.20 | 0.26 | 0.31 | 0.51 | 1.30 | 1.78 |